Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 26, Issue 12, Pages 1087-1097
Publisher
Informa UK Limited
Online
2023-01-09
DOI
10.1080/14728222.2022.2166829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
- (2021) Kenji Hashimoto EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Stimulation of Sigma-1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment
- (2021) Jing Qu et al. Oxidative Medicine and Cellular Longevity
- The proliferation effects of fluoxetine and amitriptyline on human breast cancer cells and the underlying molecular mechanisms
- (2021) Bingli Lei et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The role of the sigma-1 receptor in neuroprotection: Comment on Nrf-2 as a therapeutic target in ischemic stroke
- (2021) Mani Iyer Prasanth et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
- (2021) James Michael Brimson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac
- (2020) Sandra Bibbo’ et al. Oncogenesis
- Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain.
- (2020) James Michael Brimson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression
- (2020) James M. Brimson et al. Scientific Reports
- Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo
- (2019) Maximilian Christ et al. Cells
- Science and health for all children with cancer
- (2019) Catherine G. Lam et al. SCIENCE
- Pharmacological stimulation of sigma-1 receptor promotes activation of astrocyte via ERK1/2 and GSK3β signaling pathway
- (2019) Yun Wang et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro
- (2019) Wei-Ting Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fluoxetine Simultaneously Induces Both Apoptosis and Autophagy in Human Gastric Adenocarcinoma Cells
- (2019) Wah Wah Po et al. Biomolecules & Therapeutics
- Targeting Autophagy in Cancer: Recent Advances and Future Directions
- (2019) Ravi K. Amaravadi et al. Cancer Discovery
- Apoptotic effect of fluoxetine through the endoplasmic reticulum stress pathway in the human gastric cancer cell line AGS
- (2019) Phyu Phyu Khin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines
- (2018) James M. Brimson et al. NEUROTOXICITY RESEARCH
- Bringing down the cost of cancer treatment
- (2018) Elie Dolgin NATURE
- Life, death and autophagy
- (2018) Johnna Doherty et al. NATURE CELL BIOLOGY
- A New Approach to Treat Childhood Leukemia: Novartis' CAR-T Therapy
- (2017) Frazer A. Tessema et al. JOURNAL OF LAW MEDICINE & ETHICS
- Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
- (2017) Charbel Moussa et al. Journal of Neuroinflammation
- mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases
- (2017) Michela Palmieri et al. Nature Communications
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Are fluoxetine’s effects due to sigma-1 receptor agonism?
- (2016) S.T. Safrany et al. PHARMACOLOGICAL RESEARCH
- Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014
- (2016) Stacie B. Dusetzina JAMA Oncology
- Oncostatic effects of fluoxetine in experimental colon cancer models
- (2015) Vinicius Kannen et al. CELLULAR SIGNALLING
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs
- (2015) Teruo Hayashi JOURNAL OF PHARMACOLOGICAL SCIENCES
- Neuroimmune mechanisms of depression
- (2015) Georgia E Hodes et al. NATURE NEUROSCIENCE
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- Interleukin-2: Biology, Design and Application
- (2015) Natalia Arenas-Ramirez et al. TRENDS IN IMMUNOLOGY
- Autophagy revisited: A conversation with Christian de Duve
- (2014) Daniel J. Klionsky Autophagy
- Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells
- (2014) Tamaki Ishima et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Psychosocial and Behavioral Interventions and Cancer Patient Survival Again
- (2014) Yi Xia et al. INTEGRATIVE CANCER THERAPIES
- Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis
- (2013) Zacharias G Laoutidis et al. BMC Psychiatry
- Antidepressants: Influence on cancer and immunity?
- (2013) Luciana Romina Frick et al. LIFE SCIENCES
- Autophagy: A critical regulator of cellular metabolism and homeostasis
- (2013) Stefan W. Ryter et al. MOLECULES AND CELLS
- Antiproliferative Effects of Fluoxetine on Colon Cancer Cells and in a Colonic Carcinogen Mouse Model
- (2012) Vinicius Kannen et al. PLoS One
- Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells
- (2012) Ting Zhou et al. TUMOR BIOLOGY
- Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice
- (2011) Seong-Joon Koh et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats
- (2011) Mohammad Allahtavakoli et al. BRAIN RESEARCH BULLETIN
- Behavioural phenotyping of knockout mice for the sigma-1 (σ1) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations
- (2011) Nathalie Chevallier et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells
- (2010) Andrzej Stepulak et al. CANCER BIOLOGY & THERAPY
- Oxidative Stress-Induced Caspases are Regulated in Human Myeloid HL-60 Cells by Calcium Signal
- (2010) D. Gonzalez et al. Current Signal Transduction Therapy
- Sigma-1 receptor stimulation with fluvoxamine activates Akt–eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding
- (2010) Md. Shenuarin Bhuiyan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma
- (2010) Suzanne M. Cloonan et al. INTERNATIONAL JOURNAL OF CANCER
- The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters
- (2010) Suzanne M. Cloonan et al. LEUKEMIA & LYMPHOMA
- Fluoxetine Induces Apoptosis in Ovarian Carcinoma Cell Line OVCAR-3 Through Reactive Oxygen Species-Dependent Activation of Nuclear Factor-κB
- (2009) Chung Soo Lee et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment
- (2009) C. Song et al. PHARMACOPSYCHIATRY
- PTEN and the PI3-Kinase Pathway in Cancer
- (2008) Nader Chalhoub et al. Annual Review of Pathology-Mechanisms of Disease
- Sigma-1 receptor knockout mice display a depressive-like phenotype
- (2008) Valentina Sabino et al. BEHAVIOURAL BRAIN RESEARCH
- Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1
- (2008) Anand Krishnan et al. BIOCHEMICAL PHARMACOLOGY
- Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation
- (2008) Zhiping Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagic cell death: the story of a misnomer
- (2008) Guido Kroemer et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now